LegitScript, the leader in merchant and product certification and monitoring in the advertising, e-commerce, and payment ...

LegitScript’s traction comes as the industry gathers at ViVE 2026 in Los Angeles, where certification experts and executives will join global leaders in discussing the future of healthcare ...

PORTLAND, Ore.--(BUSINESS WIRE)--LegitScript, the leader in merchant and product certification and monitoring in the e-commerce and payment sectors, is pleased to announce several significant ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

PORTLAND, Ore.--(BUSINESS WIRE)--LegitScript, the leader in merchant and product certification and monitoring in the e-commerce and payment sectors, is waiving expedited processing fees for eligible ...

As CEO of LegitScript, Scott Roth leads the charge in redefining how digital platforms and payment ecosystems manage risk, protect users, and grow safely. With a strong track record in SaaS leadership ...

Ensuring healthy merchants are added to a portfolio, and taking care of them once they’re admitted, are two major priorities for acquirers. LegitScript, which provides merchant and product ...

LegitScript, which is backed by TJC, has acquired Kompliant, a San Jose, California-based compliance platform for banks and financial services provider. No financial terms were disclosed. LegitScript ...

PORTLAND, Ore.--(BUSINESS WIRE)--LegitScript, the leader in merchant and product certification and monitoring, today announced record growth and expanded global recognition of its healthcare ...

NEW YORK, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on creating and scaling proprietary health and ...

DISCLAIMER: This article is for informational and educational purposes only and does not constitute medical advice. GLP-1 medications require evaluation and approval by a licensed healthcare provider.